Trial Profile
Does Avastin Change Evolution in Juxtafoveal Telangiectasias?
Status:
Recruiting
Phase of Trial:
Phase III
Latest Information Update: 28 Feb 2017
Price :
$35
*
At a glance
- Drugs Bevacizumab (Primary)
- Indications Retinal telangiectasis; Telangiectasis
- Focus Therapeutic Use
- 28 Feb 2017 New trial record